Release Date: 03/05/16 08:47 Summary: Change of interests of substantial holder-BRS.AX Price Sensitive: No Download Document 240.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%